一种联合设计的CSP和Pfs48/45疟疾感染和传播阻断疫苗

Richi Gupta1, Thayne H Dickey1, Nichole D Salinas1

  • 1Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.

NPJ vaccines
|September 2, 2025
PubMed
概括

使用费里纳米颗粒的新型疟疾疫苗结合了阻断感染和阻断传播的抗原. 这种多阶段疫苗有望同时预防疟疾感染和传播.